Fresenius SE & Co. KGaA buy atalent
Start price
25.07.20
/
50%
€44.27
Target price
08.08.20
-
Performance (%)
-10.39%
End price
08.08.20
€39.67
Summary
This prediction ended on 08.08.20 with a price of €39.67. The prediction for Fresenius SE & Co. KGaA disappointed with a performance of -10.39%. atalent has 50% into this predictionFresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fresenius SE & Co. KGaA | 2.643% | 2.643% | 6.627% | -31.252% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
According to atalent what are the pros and cons of Fresenius SE & Co. KGaA for the foreseeable future?
Pros
Fair valuation
Cons
Probably not worthwhile Investment
Comments by atalent for this prediction
In the thread Fresenius SE & Co. KGaA diskutieren
Buy Fresenius SE & Co. KGaA
In the thread Trading Fresenius SE & Co. KGaA
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.